GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AddLife AB (OTCPK:ADDLF) » Definitions » COGS-to-Revenue

AddLife AB (AddLife AB) COGS-to-Revenue : 0.62 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is AddLife AB COGS-to-Revenue?

AddLife AB's Cost of Goods Sold for the three months ended in Mar. 2024 was $153.9 Mil. Its Revenue for the three months ended in Mar. 2024 was $246.8 Mil.

AddLife AB's COGS to Revenue for the three months ended in Mar. 2024 was 0.62.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. AddLife AB's Gross Margin % for the three months ended in Mar. 2024 was 37.67%.


AddLife AB COGS-to-Revenue Historical Data

The historical data trend for AddLife AB's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AddLife AB COGS-to-Revenue Chart

AddLife AB Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.66 0.66 0.64 0.62 0.63

AddLife AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.62 0.62 0.63 0.64 0.62

AddLife AB COGS-to-Revenue Calculation

AddLife AB's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=593.316 / 944.178
=0.63

AddLife AB's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=153.871 / 246.847
=0.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AddLife AB  (OTCPK:ADDLF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

AddLife AB's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 153.871 / 246.847
=37.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


AddLife AB COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of AddLife AB's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


AddLife AB (AddLife AB) Business Description

Traded in Other Exchanges
Address
Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals & laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.

AddLife AB (AddLife AB) Headlines

From GuruFocus

Full Year 2023 AddLife AB Earnings Call Transcript

By GuruFocus Research 02-05-2024